Search hospitals

>

Pennsylvania

>

Allentown

Lehigh Valley Hospital-Cedar Crest

Claim this profile

Allentown, Pennsylvania 18103

Global Leader in Lung Cancer

Global Leader in Cancer

Conducts research for Breast Cancer

Conducts research for Brain Tumor

Conducts research for Breast cancer

443 reported clinical trials

33 medical researchers

Photo of Lehigh Valley Hospital-Cedar Crest in AllentownPhoto of Lehigh Valley Hospital-Cedar Crest in AllentownPhoto of Lehigh Valley Hospital-Cedar Crest in Allentown

Summary

Lehigh Valley Hospital-Cedar Crest is a medical facility located in Allentown, Pennsylvania. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Brain Tumor, Breast cancer and other specialties. Lehigh Valley Hospital-Cedar Crest is involved with conducting 443 clinical trials across 767 conditions. There are 33 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1

Lung Cancer

Global Leader

Lehigh Valley Hospital-Cedar Crest has run 58 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I
2

Cancer

Global Leader

Lehigh Valley Hospital-Cedar Crest has run 58 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage III

Top PIs

Clinical Trials running at Lehigh Valley Hospital-Cedar Crest

Lung Cancer

Multiple Myeloma

Bladder Cancer

Breast Cancer

Esophageal cancer

Breast cancer

Ovarian Cancer

Bladder Carcinoma

Oropharyngeal Carcinoma

Non-Small Cell Lung Cancer

Image of trial facility.

Thoracotomy vs Thoracoscopy

for Metastatic Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Ceralasertib + Durvalumab

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Durvalumab

for Lung Cancer

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.

Recruiting

2 awards

Phase 3

8 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Lehigh Valley Hospital-Cedar Crest?

Where is Lehigh Valley Hospital-Cedar Crest located?

Who should I call to ask about financial aid or insurance network?

What insurance does Lehigh Valley Hospital-Cedar Crest accept?

What awards or recognition has Lehigh Valley Hospital-Cedar Crest received?